Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Journal of Cellular Physiology|July 8, 1999
Role of diacylglycerol (DAG) in hormonal induction of S phase in hepatocytes: the DAG-dependent protein kinase C pathway is not activated by epidermal growth factor (EGF), but is involved in mediating the enhancement of responsiveness to EGF by vasopressin, angiotensin II, and norepinephrineO F Dajani, D Sandnes, O Melien, et al.FEBS Letters|May 26, 1998
Insulin receptor-deficient cells as a new tool for dissecting complex interplay in insulin and insulin-like growth factorsB Lamothe, A Baudry, C T Christoffersen, et al.Journal of Medicinal Chemistry|September 23, 2010
Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for α(1)-adrenoceptorsJesper L Kristensen, Ask Püschl, Martin Jensen, et al.Molecular Carcinogenesis|July 20, 2000
Impaired nuclear accumulation and shortened phosphorylation of ERK after growth factor stimulation in cultured hepatocytes from rats exposed to 2-acetylaminofluoreneE Skarpen, B Lindeman, G H Thoresen, et al.Journal of Cellular Physiology|September 1, 1995
On the mechanisms of the growth-promoting effect of prostaglandins in hepatocytes: the relationship between stimulation of DNA synthesis and signaling mediated by adenylyl cyclase and phosphoinositide-specific phospholipase CM Refsnes, O F Dajani, D Sandnes, et al.Biochemical and Biophysical Research Communications|June 4, 1998
Insulin and insulin-like growth factor-I receptor mediated differentiation of 3T3-F442A cells into adipocytes: effect of PI 3-kinase inhibitionC T Christoffersen, H Tornqvist, C J Vlahos, et al.Growth Factors (Chur, Switzerland)|March 28, 2018
Differential effects of epidermal growth factor (EGF) receptor ligands on receptor binding, downstream signalling pathways and DNA synthesis in hepatocytesJ Ødegård, J E Sondresen, M Aasrum, et al.Diabetologia|July 1, 1997
Mitogenic properties of insulin and insulin analogues mediated by the insulin receptorD Ish-Shalom, C T Christoffersen, P Vorwerk, et al.Journal of Medicinal Chemistry|August 6, 2010
Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potentialAnette G Sams, Morten Hentzer, Gitte K Mikkelsen, et al.Bioorganic & Medicinal Chemistry|December 4, 2013
Synthesis and SAR study of a novel series of dopamine receptor agonistsRune Risgaard, Martin Jensen, Morten Jørgensen, et al.Pageof 11